Corcept Therapeutics Incorporated (CORT) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Corcept Therapeutics Incorporated (CORT) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

CORT Income Statement

Corcept Therapeutics Incorporated (CORT) annual income statement — 23-year revenue, gross profit & net income history

Annual Quarterly

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	340.47M	256.15M	164.9M	202.13M	207.64M	194.43M	157.21M	181.89M	182.55M	163.8M	146.81M	135.41M	123.6M	117.72M	105.65M	103.06M	101.73M	103.39M	93.69M	98.82M
Revenue Growth %	63.97%	31.74%	4.89%	11.12%	13.75%	18.7%	7.09%	34.33%	47.69%	39.15%	38.95%	31.39%	21.5%	13.86%	12.77%	4.28%	5.82%	12.88%	17.94%	15.26%
Cost of Goods Sold	4.61M	4.06M	2.88M	2.54M	4.6M	3.43M	2.4M	2.96M	2.87M	2.52M	2.54M	1.88M	1.65M	1.57M	1.39M	1.48M	1.34M	1.32M	1.25M	1.35M
COGS % of Revenue	1.35%	1.59%	1.75%	1.26%	2.21%	1.77%	1.53%	1.63%	1.57%	1.54%	1.73%	1.39%	1.33%	1.34%	1.31%	1.44%	1.32%	1.27%	1.33%	1.37%
Gross Profit	335.86M	252.09M	162.02M	199.58M	203.04M	191M	154.81M	178.93M	179.68M	161.27M	144.27M	133.53M	121.96M	116.14M	104.27M	101.58M	100.39M	102.07M	92.44M	97.47M
Gross Margin %	98.65%	98.41%	98.25%	98.74%	97.79%	98.23%	98.47%	98.37%	98.43%	98.46%	98.27%	98.61%	98.67%	98.66%	98.69%	98.56%	98.68%	98.73%	98.67%	98.63%
Gross Profit Growth %	65.42%	31.98%	4.66%	11.54%	13%	18.43%	7.3%	34%	47.33%	38.86%	38.37%	31.46%	21.48%	13.79%	12.8%	4.21%	5.83%	13.15%	18.25%	15.37%
Operating Expenses	221.14M	210.79M	211.62M	195.09M	192.82M	164.32M	151.4M	153.67M	133.08M	125.68M	114.77M	101.86M	90.78M	86.56M	89.42M	79.08M	68.45M	70.64M	65.67M	60.8M
OpEx % of Revenue	64.95%	82.29%	128.33%	96.52%	92.86%	84.51%	96.3%	84.49%	72.9%	76.73%	78.18%	75.23%	73.45%	73.53%	84.63%	76.73%	67.29%	68.32%	70.09%	61.53%
Selling, General & Admin	164.43M	156.9M	145.36M	130.24M	123.98M	103.85M	90.66M	83.37M	73.75M	66.94M	56.27M	47.15M	45.26M	43.28M	48.56M	42.32M	35.16M	37.81M	37.55M	32.28M
SG&A % of Revenue	48.3%	61.25%	88.15%	64.43%	59.71%	53.41%	57.67%	45.84%	40.4%	40.86%	38.33%	34.82%	36.62%	36.77%	45.97%	41.07%	34.57%	36.57%	40.08%	32.67%
Research & Development	56.71M	53.89M	66.27M	64.86M	68.85M	60.47M	60.73M	70.3M	59.34M	58.74M	58.51M	54.71M	45.52M	43.28M	40.85M	36.75M	33.29M	32.83M	28.12M	28.52M
R&D % of Revenue	16.66%	21.04%	40.18%	32.09%	33.16%	31.1%	38.63%	38.65%	32.5%	35.86%	39.85%	40.4%	36.83%	36.76%	38.66%	35.66%	32.73%	31.75%	30.01%	28.86%
Other Operating Expenses	0	0	0	1	0	0	0	0	0	500K	0	0	0	0	0	0	0	0	0	0
Operating Income	114.72M	41.3M	-49.6M	4.49M	10.22M	26.68M	3.42M	25.26M	46.6M	35.59M	29.5M	31.67M	31.18M	29.58M	14.85M	22.5M	31.93M	31.43M	26.77M	36.66M
Operating Margin %	33.7%	16.12%	-30.08%	2.22%	4.92%	13.72%	2.17%	13.89%	25.53%	21.73%	20.09%	23.39%	25.22%	25.13%	14.06%	21.83%	31.39%	30.4%	28.57%	37.1%
Operating Income Growth %	1022.65%	54.83%	-1552.02%	-82.24%	-78.07%	-25.05%	-88.42%	-20.23%	49.46%	20.31%	98.61%	40.76%	-2.37%	-5.88%	-44.51%	-38.63%	-11.86%	-1.6%	36.31%	20.17%
EBITDA	115.75M	42.16M	-49M	4.97M	10.7M	27.14M	3.88M	25.72M	47.1M	35.85M	29.62M	32.24M	31.47M	29.89M	15.14M	23.25M	32.69M	32.1M	27.57M	37.46M
EBITDA Margin %	34%	16.46%	-29.72%	2.46%	5.15%	13.96%	2.47%	14.14%	25.8%	21.89%	20.18%	23.81%	25.46%	25.39%	14.33%	22.56%	32.13%	31.05%	29.43%	37.91%
EBITDA Growth %	982.18%	55.33%	-1363.62%	-80.68%	-77.29%	-24.28%	-86.91%	-20.22%	49.68%	19.94%	95.59%	38.69%	-3.73%	-6.89%	-45.07%	-37.95%	-11.67%	-1.83%	35.28%	20.56%
D&A (Non-Cash Add-back)	1.03M	863K	598K	482K	477K	469K	462K	460K	499K	257K	120K	572K	289K	305K	291K	747K	752K	668K	802K	797K
EBIT	120.31M	45.93M	-44.72M	9.91M	15.24M	31.69M	9.62M	31.96M	52.94M	41.6M	34.99M	31.67M	31.18M	29.58M	14.85M	22.5M	31.93M	31.43M	26.77M	36.66M
Net Interest Income	0	0	4.89M	5.42M	5.02M	5.02M	6.2M	6.7M	6.34M	6M	5.49M	5.14M	5.21M	3.35M	3.58M	1.78M	1.07M	630K	80K	72K
Interest Income	0	0	4.89M	5.42M	5.02M	5.02M	6.2M	6.7M	6.34M	6M	5.49M	5.14M	5.21M	3.35M	3.58M	1.78M	1.07M	630K	80K	72K
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	5.58M	4.63M	4.89M	5.42M	5.02M	5.02M	6.2M	6.7M	6.34M	6M	5.49M	5.14M	5.21M	3.35M	3.58M	1.78M	1.07M	630K	80K	72K
Pretax Income	120.31M	45.93M	-44.72M	9.91M	15.24M	31.69M	9.62M	31.96M	52.94M	41.6M	34.99M	36.81M	36.38M	32.93M	18.43M	24.28M	33M	32.06M	26.85M	36.74M
Pretax Margin %	35.34%	17.93%	-27.12%	4.9%	7.34%	16.3%	6.12%	17.57%	29%	25.39%	23.84%	27.18%	29.44%	27.97%	17.45%	23.56%	32.44%	31.01%	28.66%	37.17%
Income Tax	-6.47M	-2.94M	-13.51M	-14.38M	-4.42M	-3.46M	-10.93M	1.21M	5.73M	6.11M	7.23M	5.45M	5.01M	5.4M	2.56M	7.67M	-1.6M	4.65M	4.05M	4.68M
Effective Tax Rate %	-5.38%	-6.41%	30.22%	-145.09%	-29.03%	-10.91%	-113.63%	3.8%	10.82%	14.68%	20.66%	14.82%	13.76%	16.4%	13.86%	31.62%	-4.86%	14.5%	15.09%	12.75%
Net Income	126.78M	42.14M	-31.2M	24.29M	19.67M	35.15M	20.55M	30.39M	46.69M	35.49M	27.76M	31.36M	31.38M	27.53M	15.88M	16.6M	34.61M	27.41M	22.8M	32.05M
Net Margin %	37.24%	16.45%	-18.92%	12.02%	9.47%	18.08%	13.07%	16.71%	25.58%	21.67%	18.91%	23.16%	25.39%	23.39%	15.03%	16.11%	34.02%	26.51%	24.33%	32.44%
Net Income Growth %	544.59%	19.89%	-251.86%	-20.08%	-57.88%	-0.96%	-25.99%	-3.08%	48.8%	28.92%	74.83%	88.87%	-9.33%	0.42%	-30.35%	-48.21%	13.58%	3.35%	-2.85%	23.31%
Net Income (Continuing)	126.78M	48.88M	-31.2M	24.29M	19.67M	35.15M	20.55M	30.75M	47.21M	35.49M	27.76M	31.36M	31.38M	27.53M	15.88M	16.6M	34.61M	27.41M	22.8M	32.05M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	1.01	0.36	-0.30	0.20	0.16	0.29	0.17	0.26	0.41	0.32	0.25	0.28	0.28	0.25	0.14	0.14	0.30	0.24	0.20	0.26
EPS Growth %	531.25%	24.14%	-276.47%	-23.08%	-60.98%	-9.38%	-32%	-7.14%	46.43%	28%	78.57%	100%	-6.67%	4.17%	-30%	-46.15%	25%	14.29%	11.11%	30%
EPS (Basic)	1.17	0.40	-0.30	0.23	0.19	0.33	0.19	0.29	0.45	0.34	0.27	0.30	0.31	0.27	0.15	0.15	0.30	0.24	0.20	0.28
Diluted Shares Outstanding	123.2M	118.39M	104.44M	119.86M	119.44M	120.48M	119.82M	118.46M	113.72M	111.24M	109.92M	110.89M	111.1M	109.59M	115.42M	116.33M	116.62M	115.4M	115.04M	122.43M
Basic Shares Outstanding	106.63M	105.38M	104.44M	103.69M	103.55M	104.11M	104.11M	103.64M	103.37M	103.12M	102.79M	102.45M	102.01M	101.96M	107.89M	107.7M	115.17M	114.16M	113.98M	113.74M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-